ArticleCVIR endovascular2026
Superior hypogastric nerve block versus spinal anesthesia for early pain control after uterine fibroid embolization: a prospective quasi-randomized comparative study.
Article in CVIR endovascular, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare early postprocedural pain and rescue opioid use after uterine fibroid embolization (UFE) in patients treated with superior hypogastric nerve block (SHNB) versus spinal anesthesia. MATERIALS AND
methodsThis single-center prospective quasi-randomized comparative study included consecutive women with symptomatic intramural uterine fibroids treated between March 2022 and October 2023. Patients were allocated according to a predefined alternating sequence to SHNB or spinal anesthesia. Allocation concealment was not used, and patients, treating teams, and outcome assessors were not blinded. Pain was assessed at 1, 6, and 18 h after embolization using a 0-10 visual numeric scale. Rescue analgesia consisted of 3 mg intravenous morphine for moderate or severe pain according to a standardized institutional protocol. The primary endpoint was any rescue morphine use during the 18-h postprocedural observation period. Secondary endpoints were total rescue morphine dose and pain scores over time. Pain trajectory was analyzed using linear mixed-effects models, and rescue morphine outcomes were analyzed using modified Poisson and Poisson regression models.
resultsForty-two patients were included, with 21 in each group. Baseline characteristics were reasonably balanced, with all absolute standardized mean differences below 0.40. Rescue morphine use occurred in 13 of 21 patients (61.9%) in each group (risk ratio, 1.00; 95% confidence interval (CI), 0.62-1.61). No significant treatment-by-time interaction was observed for pain trajectory (P = .650), and time-specific between-group differences in pain scores were not significant at 1, 6, or 18 h. In adjusted analyses, treatment group was not associated with pain trajectory, any rescue morphine use, or total rescue morphine dose. Larger fibroid diameter was associated with higher pain burden and greater morphine requirement. SHNB was technically successful in all patients and was not associated with block-related complications during the assessed follow-up window.
conclusionIn this small prospective quasi-randomized comparative study, no detectable between-group differences were observed in rescue morphine use or early postprocedural pain scores between SHNB and spinal anesthesia after UFE. These exploratory findings support the feasibility of SHNB as a procedural analgesic strategy but should not be interpreted as evidence of equivalence or noninferiority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.